STK11 and fatty liver disease: Furthermore, Kim et al. (33) demonstrated that folic acid supplementation activates the liver kinase B (LKB1)/AMP-activated protein kinase (AMPK)/acetyl coenzyme A carboxylase (ACC) pathway, increases hepatic S-adenosylmethionine, and inhibits hepatic lipogenesis, ultimately improving hepatic steatosis.